You are here

patents

Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too

Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too

Endpoints

Flag link:

What does Brexit mean for biopharma companies?

What does Brexit mean for biopharma companies?

Biopharma Reporter

Flag link:

Which pharmaceutical drugs have the most patents?

Which pharmaceutical drugs have the most patents?

Drug Patent Watch

Flag link:

Merck comes up short in last-ditch effort to revive $2.54B patent verdict against Gilead

Merck comes up short in last-ditch effort to revive $2.54B patent verdict against Gilead

Fierce Pharma

Gilead Sciences

Flag link:

Amarin vs. the Generics: Who Will Win?

Amarin vs. the Generics: Who Will Win?

Motley Fool

Flag link:

Major generic makers will partner with Medicines Patent Pool to pursue voluntary licenses for Covid-19 drugs

Major generic makers will partner with Medicines Patent Pool to pursue voluntary licenses for Covid-19 drugs

Stat

Flag link:

Testing requirements are likely slowing biosimilar entries in the US

Testing requirements are likely slowing biosimilar entries in the US

RAPS.org

Flag link:

Covid-19 Vaccine Frontrunner Moderna Won’t Enforce Vaccine Patents During Pandemic

Covid-19 Vaccine Frontrunner Moderna Won’t Enforce Vaccine Patents During Pandemic

Forbes

Moderna Therapeutics

Flag link:

Teva back on the hook for $235M to GSK for heart drug infringement

Teva back on the hook for $235M to GSK for heart drug infringement

Fierce Pharma

Patent Infringement

Flag link:

Medtronic Takes the Gloves Off in Patent War with Axonics

Medtronic Takes the Gloves Off in Patent War with Axonics

Medical Devices and Diagnostics Industry

sacral neuromodulation

Flag link:

Amarin loses patent appeal and their brief grip on a cardiovascular, fish oil empire

Amarin loses patent appeal and their brief grip on a cardiovascular, fish oil empire

Endpoints

Flag link:

Amarin Patent Appeal Is a Coin Toss With Billions on the Line

Amarin Patent Appeal Is a Coin Toss With Billions on the Line

Yahoo/Bloomberg

Flag link:

AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman

AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman

Fierce Pharma

Flag link:

Moderna failed to disclose federal funding for vaccine patent applications, advocates say

Moderna failed to disclose federal funding for vaccine patent applications, advocates say

Stat

Moderna Therapeutics

Department of Defense

Flag link:

U.S. court upholds patent for Novartis MS drug Gilenya

U.S. court upholds patent for Novartis MS drug Gilenya

Reuters

multiple sclerosis

Flag link:

Bristol Myers, Pfizer fend off a key challenge to their top-selling heart drug

Bristol Myers, Pfizer fend off a key challenge to their top-selling heart drug

BioPharma Dive

Bristol-Myers Squibb

Flag link:

Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections

Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections

CP Wire

Chelation Partners

antibiotic resistance

Flag link:

Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections

Chelation Partners

antibiotic resistance

Flag link:

Moderna's Vaccine Technology Continues to be Tangled in Patent Challenges

Moderna's Vaccine Technology Continues to be Tangled in Patent Challenges

BioSpace

Moderna Therapeutics

Arbutus BioPharma

Flag link:

Moderna's stock falls the day after 'disappointing' patent ruling

Moderna's stock falls the day after 'disappointing' patent ruling

Marketwatch

Moderna Therapeutics

Arbutus BioPharma

Flag link:

Pages